当前位置:
X-MOL 学术
›
J. Clinical Psychopharmacol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Finding Early Improvement Threshold to Predict Response After 8 Weeks of Treatment Using Risperidone in First-Episode Psychosis.
Journal of Clinical Psychopharmacology ( IF 2.9 ) Pub Date : 2020-12-22 , DOI: 10.1097/jcp.0000000000001331 Viswam Subeesh 1 , Eswaran Maheswari 1 , Hemendra Singh 2 , Reddy Neha 1 , Faizan Mazhar 3
Journal of Clinical Psychopharmacology ( IF 2.9 ) Pub Date : 2020-12-22 , DOI: 10.1097/jcp.0000000000001331 Viswam Subeesh 1 , Eswaran Maheswari 1 , Hemendra Singh 2 , Reddy Neha 1 , Faizan Mazhar 3
Affiliation
The study aims to assess whether the early response can predict the outcome at the endpoint for the treatment of first-episode psychosis with risperidone and identify the relationship between initial symptom reduction and late response.
中文翻译:
在首发精神病中使用利培酮治疗 8 周后发现早期改善阈值以预测反应。
该研究旨在评估早期反应是否可以预测利培酮治疗首发精神病的终点结果,并确定初始症状减轻与晚期反应之间的关系。
更新日期:2020-12-23
中文翻译:
在首发精神病中使用利培酮治疗 8 周后发现早期改善阈值以预测反应。
该研究旨在评估早期反应是否可以预测利培酮治疗首发精神病的终点结果,并确定初始症状减轻与晚期反应之间的关系。